In HepG2 cells, we found EZH2 binds to the genes highly expressed in HCC patients, including those genes participating in the cancer pathway, indicating that EZH2 performs transcription activation roles in HCC by interacting with other proteins. The gene discussed is EZH2; the disease is cancer.